These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33022543)

  • 1. Modulation of myeloid cells by adenosine signaling.
    Cekic C
    Curr Opin Pharmacol; 2020 Aug; 53():134-145. PubMed ID: 33022543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
    Silva-Vilches C; Ring S; Mahnke K
    Front Immunol; 2018; 9():2581. PubMed ID: 30473700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory activity of adenosine and its role in human cancer progression.
    Muller-Haegele S; Muller L; Whiteside TL
    Expert Rev Clin Immunol; 2014 Jul; 10(7):897-914. PubMed ID: 24871693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine signaling and the immune system: When a lot could be too much.
    Antonioli L; Fornai M; Blandizzi C; Pacher P; Haskó G
    Immunol Lett; 2019 Jan; 205():9-15. PubMed ID: 29702147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulation of adenosine receptors on myeloid cells enhance leukocyte migration at the site of burn injury].
    Iur'eva KS; Nevskaia KV; Dziuman AN; Ikkert OP; Ivanov VV; Saltykova IV; Sazonov AÉ; Ogorodova LM
    Biomed Khim; 2014; 60(2):246-57. PubMed ID: 24837313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
    Safarzadeh E; Jadidi-Niaragh F; Motallebnezhad M; Yousefi M
    Inflamm Res; 2016 Jul; 65(7):511-20. PubMed ID: 26960979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of leukocyte function by adenosine receptors.
    Linden J
    Adv Pharmacol; 2011; 61():95-114. PubMed ID: 21586357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
    Majumdar S; Aggarwal BB
    Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase D, ubiquitin and proteasome pathways are involved in adenosine receptor-stimulated NR4A expression in myeloid cells.
    Giffney HE; Cummins EP; Murphy EP; Brayden DJ; Crean D
    Biochem Biophys Res Commun; 2021 May; 555():19-25. PubMed ID: 33812054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological alterations mediated by adenosine during host-microbial interactions.
    Drygiannakis I; Ernst PB; Lowe D; Glomski IJ
    Immunol Res; 2011 May; 50(1):69-77. PubMed ID: 21479929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
    Yim LY; Lau CS; Chan VS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Gut Inflammation by Modulation of Purinergic Signaling.
    Vuerich M; Mukherjee S; Robson SC; Longhi MS
    Front Immunol; 2020; 11():1882. PubMed ID: 33072065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine Receptor Signaling Targets Both PKA and Epac Pathways to Polarize Dendritic Cells to a Suppressive Phenotype.
    Kayhan M; Koyas A; Akdemir I; Savas AC; Cekic C
    J Immunol; 2019 Dec; 203(12):3247-3255. PubMed ID: 31722989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.
    Haskó G; Linden J; Cronstein B; Pacher P
    Nat Rev Drug Discov; 2008 Sep; 7(9):759-70. PubMed ID: 18758473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine and Inflammation: Here, There and Everywhere.
    Pasquini S; Contri C; Borea PA; Vincenzi F; Varani K
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis.
    Jantsch J; Schödel J
    Immunobiology; 2015 Feb; 220(2):305-14. PubMed ID: 25439732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the CD73-adenosine axis in immuno-oncology.
    Allard D; Chrobak P; Allard B; Messaoudi N; Stagg J
    Immunol Lett; 2019 Jan; 205():31-39. PubMed ID: 29758241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity.
    Vuerich M; Harshe RP; Robson SC; Longhi MS
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.